Our observations indicate that loss of growth response to TGF-β in CC could originate from decreased cellular TGF-βRII expression because the lower TGF-βRII level in estrogen-treated K14-E7, as compared to that found in nontransgenic mice may contribute to cervical cancer. The gene discussed is TGFB1; the disease is cervical cancer.